Optimization of the fermentation parameters for Echinocandin B production in 5 L bioreactor

  • HU Xiao-long ,
  • QIN Hai-bin ,
  • WU Xu-ping ,
  • MAO Jian ,
  • ZOU Shu-ping ,
  • NIU Kun
Expand
  • (Key Laboratory of Bioorganic Synthesis of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, China)

Received date: 2018-04-05

  Online published: 2018-10-30

Abstract

Echinocandin B (ECB) is the key precursor of anidufungin, mainly synthesized by microbial fermentation. In this experiment, the scale-up conditions of Aspergillus nidulans ZJB09223 for ECB fermentation was optimized in the fermentor. The effects of different types of agitating paddles, stirring speed and aeration volume on the Echinocandin B fermentation were investigated to achieve the basic conditions of industrialization. The comparison of different impeller types showed that flat-straight leaf disc tubine type agitator was more suitable for ECB fermentation process. The optimum aeration amount was 1.7 VVM, and the stirring speed was 600 r/min in the first 6 days and 400 r/min in the next 9 days to obtain the best results of 608 mg/L, which was 193% higher than that under the original conditions.

Cite this article

HU Xiao-long , QIN Hai-bin , WU Xu-ping , MAO Jian , ZOU Shu-ping , NIU Kun . Optimization of the fermentation parameters for Echinocandin B production in 5 L bioreactor[J]. Food and Fermentation Industries, 2018 , 44(9) : 130 -135 . DOI: 10.13995/j.cnki.11-1802/ts.017467

References

[1] NYFELER R W, KELLER S. Metabolites of microorganisms.143: Echinocandin B, a novel polypeptide-antibiotic from Aspergillus nidulans var. echinulatus: isolation and structural components [J]. Helvetica Chimica Acta, 1974, 57(8): 2 459-2 477.
[2] AIKAWA N, KUSACHI S, ODA S, et al. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm [J]. Journal of Infection & Chemotherapy, 2009, 15(4): 219-227.
[3] STAN C D, TUCHILUS C, STAN C I. Echinocandins – new antifungal agents [J]. Revista Medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 2014, 118 (2): 528-536.
[4] EMRI T, MAJOROS L, TOTH V, et al. Echinocandins: production and applications [J]. Applied Microbiology and Biotechnology, 2013, 97(8): 3 267-3 284.
[5] ROBBINS N, WRIGHT G D, COWEN L E. Antifungal drugs: the current armamentarium and development of new agents [J]. Microbiology Spectrum, 2016, 4(5).DOI:10.1128/microbiolspec. FUNK-0002-2016.
[6] PAPAGIANNI M. Fungal morphology and metabolite production in submerged mycelial processes [J]. Biotechnology Advances, 2012, 22(3): 189-259.
[7] TOTH V. Characterization of Aspergillus nidulans var. roseus ATCC 58397, investigation its echinocandin B and sterigmatocystin production [D]. Hungary: University of Debrecen, 2012.
[8] CACHO R A, JIANG W, CHOOI Y H, et al. Identification and characterization of the echinocandin B biosynthetic gene cluster from Emericella rugulosa NRRL 11440 [J]. Journal of the American Chemical Society, 2012, 134(40): 16 781-16 790.
[9] 上海医药工业研究院. 制备棘球康定B的方法:中国,CN 101659692 [P]. 2010-03-03.
[10] 华北制药集团新药研究开发有限责任公司. 一种高纯度棘白菌素B的制备方法: 中国,CN 102952180A [P]. 2013-03-06.
[11] 上海医药工业研究院, 中国医药工业研究总院. 一种用于生产棘白菌素B的培养基:中国,CN 103205479A [P]. 2013-07-17.
[12] HU Z C, PENG L Y, ZHENG Y G. Enhancement of echinocandin B production by a UV- and microwave-induced mutant of Aspergillus nidulans with precursor-and biotin-supplying strategy [J]. Applied Biochemistry & Biotechnology, 2016, 179(7):1 213-1 226.
[13] ZOU S P, ZHONG W, XIA C J, et al. Mutagenesis breeding of high echinocandin B producing strain and further titer improvement with culture medium optimization[J]. Bioprocess and Biosystems Engineering, 2015, 38(10): 1 845.
[14] ZOU S P, LIU M, WANG Q L, et al. Preparative separation of echinocandin B from Aspergillus nidulans broth using macroporous resin adsorption chromatography[J]. Journal of Chromatography B, 2015(978-979): 111-117.
[15] JENNINGS D H. Polyol metabolism in fungi [J]. Advances in Microbial Physiology, 1985, 25(4): 149-193.
Outlines

/